All Stories

Tom Winnifrith Bonus Bearcast: Today's note from Cavendish on Skinbiotherapeutics is utterly pointless, here's my stab at forecasts

Tom Winnifrith
Wednesday 20 November 2024
What is the point of Nomad and broker Cavendish? Giles Bellend lies to his client. Now it publishes a wholly pointless and amateurish research note on Sinbiotherapeutics (SBTX). I discuss that note and have a stab at doing the analyst's job for him.

on Tom Winnifrith | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Recently Featured on ShareProphets
Sign up for my weekly newsletter








Required Reading

Recent Comments


I also read